Drug intelligence / Profile preview

Diyu Huaijiao Pills

Development stage: Unknown
Lead developer: Lanzhou Foci
Modality: Small Molecules
Administration: Oral

Overview

Diyu Huaijiao Pills is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Lanzhou Foci. Administered orally, it is primarily indicated for the treatment of hemorrhoids, particularly internal hemorrhoids associated with rectal bleeding (hematochezia), as well as constipation and anal swelling or pain. According to TCM principles, the medication functions by clearing damp-heat from the intestines, cooling the blood to stop bleeding, dispersing wind, and regulating qi to alleviate pain. The product is approved and marketed in China, with Lanzhou Foci receiving supplemental approval for the formulation in 2018.

Brand names: Foci
Other names: 地榆槐角丸Diyu Huaijiao Wan

Beyond the preview

Go deeper on Diyu Huaijiao Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diyu Huaijiao Pills.

Explore the full profile